Results 141 to 150 of about 517,662 (262)

Interlaboratory clinical chemistry parameter variation in seven-day acute hydrazine toxicity studies in the Sprague-Dawley rat. [PDF]

Arch Toxicol
Kadyrov J, Sala S, Grigoroff L, Masuda R, Lodge S, Ebbels TM, Reily MD, Robertson D, Lehman-McKeeman L, Shockcor J, Car BD, Thomas C, Lindon JC, Wist J, Nicholson JK, Holmes E.   +15 more
europepmc   +1 more source

Lot verification practices in Ontario clinical chemistry laboratories - Results of a patterns-of-practice survey. [PDF]

Pract Lab Med, 2022
Rutledge AC, Johnston A, Booth RA, Veljkovic K, Bailey D, Vandenberghe H, Waite G, Allen LC, Don-Wauchope A, Chan PC, Stemp J, Edmond P, Leung V, Aslan B.   +13 more
europepmc   +1 more source

Bibliometrics and clinical chemistry

Clinical Chemistry, 1991
C, Campos, F L, Redondo
openaire   +2 more sources

MITF maintains genome stability in nonmelanocyte lineages

Molecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir, Adrián López García de Lomana, Thejus B. Venkatesh, Kritika Kirty, Snaevar Sigurdsson, Linda Vidarsdottir, Ramile Dilshat, Erla Sveinbjornsdottir, Snaedis Ragnarsdottir, Daniel H Magnusson, Maria R. Bustos, Eirikur Steingrimsson, Thorkell Gudjonsson, Stefan Sigurdsson   +13 more
wiley   +1 more source

Early Post-Transplant Protein Biomarkers for Risk Stratification of Renal Allograft Dysfunction: Diagnostic Value and Clinical Chemistry Perspectives. [PDF]

Diseases
Bot Rachisan AL, Aldea PL, Bulata B, Delean D, Elec F, Sparchez M.   +5 more
europepmc   +1 more source

Insights and prospects for ion mobility-mass spectrometry in clinical chemistry. [PDF]

Expert Rev Proteomics, 2022
Koomen DC, May JC, McLean JA.
europepmc   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Performance Analysis of Clinical Chemistry Laboratory Using Sigma Metrics in the Total Testing Process at Dessie Comprehensive Specialized Hospital, Ethiopia. [PDF]

J Clin Lab Anal
Mulatie Z, Ebrahim E, Alebachew M, Gedefie A, Eshetu B, Tilahun M, Debash H, Kassa Y, Alemayehu E, Gessese T.   +9 more
europepmc   +1 more source

Clinical Chemistry for Developing Countries: Mass Spectrometry. [PDF]

Annu Rev Anal Chem (Palo Alto Calif), 2021
Lee S, Chintalapudi K, Badu-Tawiah AK.
europepmc   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

Molecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu, Nicolas J. Niklaus, Anna M. Schläfli, Igor Tokarchuk, Magali Humbert, Federico La Manna, Bich Vu, David Maul, Ramin Radpour, Marianna Kruithof‐de Julio, Inti Zlobec, Jörn Dengjel, Bruce E. Torbett, Mario P. Tschan   +13 more
wiley   +1 more source